Computed Tomography Market Growth, Trends, Demand & Forecast 2024-2032

IMARC Group's report titled "Computed Tomography Market by Type (Low Slice, Medium Slice, High Slice, Cone Beam), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032", The global computed tomography market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.27% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/computed-tomography-market/requestsample

Factors Affecting the Growth of the Computed Tomography Industry:

  • Technological Advancements and Innovation:

The continuous evolution of computed tomography (CT) technology is impelling the growth of the market. Innovations, such as high-resolution imaging, faster scan times, and the development of multi-slice CT scanners, are significantly improving the accuracy and efficiency of CT imaging. These advancements not only enhance diagnostic capabilities but also reduce patient exposure to radiation. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) algorithms in CT imaging allows for more precise image analysis and interpretation. AI-driven features help in detecting abnormalities more quickly and accurately, leading to better patient outcomes. The ongoing research and development (R&D) in this field facilitates further enhancements, making CT a more powerful tool for diagnostics and treatment planning.

  • Increasing Prevalence of Chronic Diseases:

The rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, is driving the demand for advanced diagnostic tools like CT scanners. Early and accurate diagnosis is crucial for effective treatment and management of these conditions. CT imaging plays a vital role in the early detection of tumors, the assessment of vascular conditions, and the evaluation of various neurological disorders. As the global population ages, the prevalence of age-related chronic diseases is increasing, further driving the demand for CT imaging. Healthcare providers are relying on CT technology to improve diagnostic accuracy and enhance patient care.

  • Growing Demand for Non-Invasive Diagnostic Techniques:

The growing preference for non-invasive diagnostic methods among both healthcare providers and patients is offering a favorable market outlook. CT imaging is a non-invasive technique that provides detailed cross-sectional images of the body, allowing for accurate diagnosis without the need for surgical intervention. This aspect is particularly appealing to patients who are apprehensive about invasive procedures. The ability of CT scanners to quickly and non-invasively diagnose a wide range of conditions, from fractures and infections to cancers and cardiovascular diseases, is a significant advantage. Moreover, the increasing awareness about the benefits of early diagnosis and preventive healthcare is leading to higher utilization rates of CT imaging.

Leading Companies Operating in the Global Computed Tomography Industry:

  • Canon Medical Systems Corporation (Canon Inc.)
  • FUJIFILM Holdings Corporation
  • GE HealthCare (General Electric Company)
  • Koning Corporation
  • Koninklijke Philips N.V.
  • NeuroLogica Corp. (Samsung Electronics Co. Ltd.)
  • Neusoft Medical Systems Co. Ltd. (Neusoft Corporation)
  • Planmeca Oy
  • Siemens Healthineers AG (Siemens AG)
  • Stryker Corporation

Computed Tomography Market Report Segmentation:

By Type:

  • Low Slice
  • Medium Slice
  • High Slice
  • Cone Beam

High slice represents the leading segment as it offers numerous benefits that significantly enhance diagnostic capabilities and patient care.

By Application:

  • Oncology
  • Neurology
  • Cardiovascular
  • Musculoskeletal
  • Others

Oncology accounts for the majority of the market share due to the advanced dose-reduction technologies in CT scanners that minimize patient exposure to ionizing radiation.

By End User:

  • Hospitals
  • Diagnostic Centers
  • Others

Hospitals hold the biggest market share owing to the rising number of patients seeking effective healthcare services.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America's dominance in the computed tomography market is attributed to the growing occurrence of chronic diseases among the masses.

Global Computed Tomography Market Trends:

The growing awareness of health issues and the importance of preventive healthcare are pivotal factors driving the demand for CT imaging. As people become more informed about the benefits of early diagnosis and regular health screenings, there is an increase in the demand for comprehensive diagnostic services. CT scans provide detailed images that can help detect potential health issues at an early stage, allowing for timely intervention and better health management. Health campaigns and initiatives by governments and healthcare organizations further promote the importance of regular check-ups and diagnostic tests. This heightened awareness and emphasis on preventive healthcare contribute to the increased utilization of CT scanners.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163